Dual-responsive mPEG-PLGA-PGlu hybrid-core nanoparticles with a high drug loading to reverse the multidrug resistance of breast cancer: an in vitro and in vivo evaluation.

In this study, monomethoxy (polyethylene glycol)-b-P (d,l-lactic-co-glycolic acid)-b-P (l-glutamic acid) (mPEG-PLGA-PGlu) nanoparticles with the ability to rapidly respond to the endolysosomal pH and hydrolase were prepared and the pH-sensitivity was tuned by adjusting the length of the PGlu segment. The mPEG5k-PLGA20k-PGlu (60) nanoparticles were specifically responsive to an endosomal pH of 5.0-6.0 due to the configuration transition of the PGlu segment and rapidly initiated chemical degradation after incubation with proteinase k for 10 min. Doxorubicin hydrochloride (DOX), used as a model drug, was easily encapsulated into nanoparticles and the DOX-loaded nanoparticles (DOX-NPs) exhibited a pH-dependent and enzyme-sensitive release profile in vitro. The dual sensitivity enabled the rapid escape of DOX-loaded nanoparticles from the endolysosomal system to target cellular nuclei, which resulted in increased cell toxicity against MCF/ADR resistant breast cancer cells and a higher cellular uptake than free DOX. In Vivo Imaging studies indicated that the nanoparticles could continuously accumulate in the tumor tissues through EPR effects and Ex vivo Imaging biodistribution studies indicated that DOX-NPs increased drug penetration into tumors compared with normal tissues. The in vivo antitumor activity demonstrated that DOX-loaded NPs had less body loss and a significant regression of tumor growth, indicating the increased anti-tumor efficacy and lower systemic toxicity. Therefore, this dual sensitive nanoparticle system may be a potential nanocarrier to overcome the multidrug resistance exhibited by breast cancer.

[1]  B. Grant,et al.  Pathways and mechanisms of endocytic recycling , 2009, Nature Reviews Molecular Cell Biology.

[2]  Shen‐guo Wang,et al.  Synthesis and characterization of a functionalized biodegradable copolymer: poly(l-lactide-co-RS-β-malic acid) , 2003 .

[3]  J. Leroux,et al.  pH-sensitive vesicles, polymeric micelles, and nanospheres prepared with polycarboxylates. , 2012, Advanced drug delivery reviews.

[4]  Jennifer Sturgis,et al.  A cellular Trojan Horse for delivery of therapeutic nanoparticles into tumors. , 2007, Nano letters.

[5]  Zibin Gao,et al.  Nanotechnology applied to overcome tumor drug resistance. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[6]  G. Hsiue,et al.  Enzymatic degradation of PLLA-PEOz-PLLA triblock copolymers. , 2005, Biomaterials.

[7]  Keith M. Stantz,et al.  Delivery of nanoparticles to brain metastases of breast cancer using a cellular Trojan horse , 2012, Cancer Nanotechnology.

[8]  Jian-biao Ma,et al.  pH-responsive self-assembly and conformational transition of partially propyl-esterified poly(alpha,beta-L-aspartic acid) as amphiphilic biodegradable polyanion. , 2009, Colloids and surfaces. B, Biointerfaces.

[9]  Dennis E Discher,et al.  Self-porating polymersomes of PEG-PLA and PEG-PCL: hydrolysis-triggered controlled release vesicles. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[10]  Wei Feng,et al.  Characterization of endocytosis of transferrin-coated PLGA nanoparticles by the blood-brain barrier. , 2009, International journal of pharmaceutics.

[11]  Chen Jiang,et al.  pH-sensitive drug-delivery systems for tumor targeting. , 2013, Therapeutic delivery.

[12]  Shi Xu,et al.  Targeting receptor-mediated endocytotic pathways with nanoparticles: rationale and advances. , 2013, Advanced drug delivery reviews.

[13]  Xuesi Chen,et al.  Lactose mediated liver-targeting effect observed by ex vivo imaging technology. , 2010, Biomaterials.

[14]  Xuesi Chen,et al.  Synthesis and characterization of biodegradable amphiphilic triblock copolymers containing L-glutamic acid units. , 2005, Biomacromolecules.

[15]  A. Kabanov,et al.  Biodegradable hybrid polymer micelles for combination drug therapy in ovarian cancer. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[16]  Qiang Zhang,et al.  Synergistic effect of folate-mediated targeting and verapamil-mediated P-gp inhibition with paclitaxel -polymer micelles to overcome multi-drug resistance. , 2011, Biomaterials.

[17]  F. Kiessling,et al.  Multidrug resistance: Physiological principles and nanomedical solutions. , 2013, Advanced drug delivery reviews.

[18]  Amolkumar Karwa,et al.  In vitro efficacy of paclitaxel-loaded dual-responsive shell cross-linked polymer nanoparticles having orthogonally degradable disulfide cross-linked corona and polyester core domains. , 2013, Molecular pharmaceutics.

[19]  Hui Gao,et al.  Biodegradable and temperature-responsive polyurethanes for adriamycin delivery. , 2011, International journal of pharmaceutics.

[20]  C. Mignogna,et al.  Prognostic significance of multidrug-resistance protein (MDR-1) in renal clear cell carcinomas: A five year follow-up analysis , 2006, BMC Cancer.

[21]  H. Cui,et al.  Controlled release of free doxorubicin from peptide-drug conjugates by drug loading. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[22]  Kinam Park,et al.  Overcoming the barriers in micellar drug delivery: loading efficiency, in vivo stability, and micelle–cell interaction , 2010, Expert opinion on drug delivery.

[23]  Yali Li,et al.  Degradability of poly(lactic acid)-containing nanoparticles: enzymatic access through a cross-linked shell barrier. , 2012, Journal of the American Chemical Society.

[24]  J. Munch,et al.  Energy-dependent uptake of benzo[a]pyrene and its cytoskeleton-dependent intracellular transport by the telluric fungus Fusarium solani , 2014, Environmental Science and Pollution Research.

[25]  Jianshu Li,et al.  Doxorubicin loaded pH-responsive micelles capable of rapid intracellular drug release for potential tumor therapy. , 2014, Journal of biomedical nanotechnology.

[26]  P. Okunieff,et al.  Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. , 1989, Cancer research.

[27]  R. Haag,et al.  pH-responsive dendritic core-multishell nanocarriers. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[28]  Qin Chen,et al.  Star-shape copolymer of lysine-linked di-tocopherol polyethylene glycol 2000 succinate for doxorubicin delivery with reversal of multidrug resistance. , 2012, Biomaterials.

[29]  Alexander V Kabanov,et al.  Can nanomedicines kill cancer stem cells? , 2013, Advanced drug delivery reviews.

[30]  Sébastien Lecommandoux,et al.  A simple method to achieve high doxorubicin loading in biodegradable polymersomes. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[31]  Mark E. Davis,et al.  Nanoparticle therapeutics: an emerging treatment modality for cancer , 2008, Nature Reviews Drug Discovery.

[32]  V. Torchilin,et al.  PEG-PE-based micelles co-loaded with paclitaxel and cyclosporine A or loaded with paclitaxel and targeted by anticancer antibody overcome drug resistance in cancer cells , 2012, Drug delivery.

[33]  Vladimir P Torchilin,et al.  Nanopreparations to overcome multidrug resistance in cancer. , 2013, Advanced drug delivery reviews.

[34]  Joseph M. DeSimone,et al.  Strategies in the design of nanoparticles for therapeutic applications , 2010, Nature Reviews Drug Discovery.

[35]  A. Kabanov,et al.  Polymer micelles with cross-linked polyanion core for delivery of a cationic drug doxorubicin. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[36]  Xiabin Jing,et al.  Synthesis and characterization of RGD peptide grafted poly(ethylene glycol)-b-poly(L-lactide)-b-poly(L-glutamic acid) triblock copolymer. , 2006, Biomacromolecules.

[37]  You Han Bae,et al.  Recent progress in tumor pH targeting nanotechnology. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[38]  N. Nishiyama,et al.  In vivo antitumor activity of the folate-conjugated pH-sensitive polymeric micelle selectively releasing adriamycin in the intracellular acidic compartments. , 2007, Bioconjugate chemistry.

[39]  Xing Tang,et al.  International Journal of Nanomedicine , 2022 .

[40]  F. Sharom.  The P-glycoprotein multidrug transporter. , 2011, Essays in biochemistry.

[41]  Yaping Li,et al.  Co-delivery of doxorubicin and RNA using pH-sensitive poly (β-amino ester) nanoparticles for reversal of multidrug resistance of breast cancer. , 2014, Biomaterials.

[42]  Qiang Zhang,et al.  Chloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomes. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[43]  A. Kabanov,et al.  Polypeptide nanogels with hydrophobic moieties in the cross-linked ionic cores: synthesis, characterization and implications for anticancer drug delivery , 2013, Journal of drug targeting.

[44]  You Han Bae,et al.  Enhanced Intercellular Retention Activity of Novel pH-sensitive Polymeric Micelles in Wild and Multidrug Resistant MCF-7 Cells , 2007, Pharmaceutical Research.

[45]  Y. Bae,et al.  PEG-poly(amino acid) Block Copolymer Micelles for Tunable Drug Release , 2010, Pharmaceutical Research.

[46]  I. Sánchez-García,et al.  The theoretical basis of cancer‐stem‐cell‐based therapeutics of cancer: can it be put into practice? , 2007, BioEssays : news and reviews in molecular, cellular and developmental biology.

[47]  J. Hwang,et al.  N-acetyl histidine-conjugated glycol chitosan self-assembled nanoparticles for intracytoplasmic delivery of drugs: endocytosis, exocytosis and drug release. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[48]  Ying Sun,et al.  Toxicity and therapy of cisplatin-loaded EGF modified mPEG-PLGA-PLL nanoparticles for SKOV3 cancer in mice. , 2013, Biomaterials.

[49]  M. Zignani,et al.  Current status of pH-sensitive liposomes in drug delivery. , 2000, Progress in lipid research.